Evidence map›Paper›PMID 37046802›Full record

ArticleCancers2023

Temporal Machine Learning Analysis of Prior Mammograms for Breast Cancer Risk Prediction.

Hui Li, Kayla Robinson, Li Lan, Natalie Baughan, Chun-Wai Chan, Matthew Embury, Gary J Whitman, Randa El-Zein, Isabelle Bedrosian, Maryellen L Giger

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. New Frontiers in Breast Cancer Imaging: The Rise of AI.Bioengineering (Basel, Switzerland) · 2024
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hui LiDepartment of Radiology, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0003-3139-2898
Kayla RobinsonDepartment of Radiology, The University of Chicago, Chicago, IL 60637, USA.
Li LanDepartment of Radiology, The University of Chicago, Chicago, IL 60637, USA.
Natalie BaughanDepartment of Radiology, The University of Chicago, Chicago, IL 60637, USA.
Chun-Wai ChanDepartment of Radiology, The University of Chicago, Chicago, IL 60637, USA.
Matthew EmburyDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Gary J WhitmanDepartment of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-2002-7457
Randa El-ZeinDepartment of Radiology, Houston Methodist Research Institute, Houston, TX 77030, USA.
Isabelle BedrosianDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Maryellen L GigerDepartment of Radiology, The University of Chicago, Chicago, IL 60637, USA.
University of Chicago · USThe University of Texas MD Anderson Cancer Center · USHouston Methodist · US

Funding

RESEARCH TRAINING IN MEDICAL PHYSICST32EB002103 · NIBIB · UNIVERSITY OF CHICAGO · PI ARMATO, SAMUEL G. · 2003 to 2019
$4.7M
Integrative molecular and imaging approaches for risk of subtype specific breastU01CA189240 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI BEDROSIAN, ISABELLE, EL-ZEIN, RANDA A · 2015 to 2019
$2.9M
Quantitative Image Analysis for Assessing Response to Breast Cancer TherapyU01CA195564 · NCI · UNIVERSITY OF CHICAGO · PI GIGER, MARYELLEN L. · 2015 to 2019
$2.5M
Protected Radiomics Analysis Commons for Deep Learning in Biomedical DiscoveryS10OD025081 · OD · UNIVERSITY OF CHICAGO · PI GIGER, MARYELLEN L. · 2018 to 2018
$339k
Machine Learning in Breast Parenchyma and Tumor Characterization for Cancer Risk AssessmentF31CA228247 · NCI · UNIVERSITY OF CHICAGO · PI MENDEL, KAYLA RAE · 2019 to 2019
$24k
NCI NIH HHS F31 CA228247NCI NIH HHS U01 CA189240NCI NIH HHS U01 CA195564NIBIB NIH HHS T32 EB002103NIH HHS 1U01CA189240-01NIH HHS F31CA228247NIH HHS S10 OD025081NIH HHS T32 EB002103NIH HHS U01CA195564Susan G. Komen Breast Cancer Foundation KG090351University of Chicago Comprehensive Cancer 415 Center Koleseiki Funding N/A
6 · The paper itself

Abstract

The identification of women at risk for sporadic breast cancer remains a clinical challenge. We hypothesize that the temporal analysis of annual screening mammograms, using a long short-term memory (LSTM) network, could accurately identify women at risk of future breast cancer. Women with an imaging abnormality, which had been biopsy-confirmed to be cancer or benign, who also had antecedent imaging available were included in this case-control study. Sequences of antecedent mammograms were retrospectively collected under HIPAA-approved guidelines. Radiomic and deep-learning-based features were extracted on regions of interest placed posterior to the nipple in antecedent images. These features were input to LSTM recurrent networks to classify whether the future lesion would be malignant or benign. Classification performance was assessed using all available antecedent time-points and using a single antecedent time-point in the task of lesion classification. Classifiers incorporating multiple time-points with LSTM, based either on deep-learning-extracted features or on radiomic features, tended to perform statistically better than chance, whereas those using only a single time-point failed to show improved performance compared to chance, as judged by area under the receiver operating characteristic curves (AUC: 0.63 ± 0.05, 0.65 ± 0.05, 0.52 ± 0.06 and 0.54 ± 0.06, respectively). Lastly, similar classification performance was observed when using features extracted from the affected versus the contralateral breast in predicting future unilateral malignancy (AUC: 0.63 ± 0.05 vs. 0.59 ± 0.06 for deep-learning-extracted features; 0.65 ± 0.05 vs. 0.62 ± 0.06 for radiomic features). The results of this study suggest that the incorporation of temporal information into radiomic analyses may improve the overall classification performance through LSTM, as demonstrated by the improved discrimination of future lesions as malignant or benign. Further, our data suggest that a potential field effect, changes in the breast extending beyond the lesion itself, is present in both the affected and contralateral breasts in antecedent imaging, and, thus, the evaluation of either breast might inform on the future risk of breast cancer.

Indexed as

artificial intelligencebreast cancer riskfield effectlong short-term memory networksradiomics

Identifiers

PMID37046802
PMCPMC10093086
OpenAlexW4362640379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.